Skip to content

Clinical trials

Withdrawn Neurodegenerative Diseases trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neurodegenerative Diseases Status: Withdrawn Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20091
20102
20141
20172
20181
20211
20222
20232

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Withdrawn12

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Tammie L. S. Benzinger, MD, PhD2
Andrew Newberg1
Centre Hospitalier Universitaire de Nice1
Flowonix Medical1
Imperial College London1
Inmune Bio, Inc.1
Nantes University Hospital1
Pfizer1
Taysha Gene Therapies, Inc.1
University Hospital, Montpellier1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neurodegenerative Diseases12
Alzheimer Disease5
Dementia4
Brain Diseases3
Central Nervous System Diseases3
Cognitive Dysfunction3
Multiple Sclerosis2
Nervous System Diseases2
Parkinson Disease2
Tauopathies2

Trials

Showing 76 to 12 of 12. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.